JCI - Citations to Collagen-induced arthritis in the BB rat. Prevention of disease by treatment with CTLA-4-Ig.

Citations to this article

Collagen-induced arthritis in the BB rat. Prevention of disease by treatment with CTLA-4-Ig.

D B Knoerzer, … , B D Schwartz, L J Mengle-Gaw

D B Knoerzer, … , B D Schwartz, L J Mengle-Gaw

Published August 1, 1995
Citation Information: J Clin Invest. 1995;96(2):987-993. https://doi.org/10.1172/JCI118146.

View: Text | PDF

Research Article

Total citations by year

Year:	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	1997	1996	Total
Citations:	1	4	4	2	4	8	6	4	8	4	3	7	8	5	5	4	8	8	3	7	8	5	1	7	2	3	129

Citation information

Citations to this article (129)

Title and authors	Publication	Year
Arthritis-associated osteoclastogenic macrophages (AtoMs) participate in pathological bone erosion in rheumatoid arthritis T Agemura, T Hasegawa, S Yari, J Kikuta, M Ishii		2021
Development of an intravital imaging system for the synovial tissue reveals the dynamics of CTLA-4 Ig in vivo T Hasegawa, J Kikuta, T Sudo, E Yamashita, S Seno, T Takeuchi, M Ishii	Scientific Reports	2020
Immune checkpoint inhibitor–induced inflammatory arthritis as a model of autoimmune arthritis LC Cappelli, MA Thomas, CO Bingham, AA Shah, E Darrah	Immunological Reviews	2020
Abatacept treatment for patients with severe acute hepatitis caused by hepatitis B virus infection—Pilot study Y Teraoka, M Imamura, T Uchida, K Ohya, K Morio, H Fujino, A Ono, T Nakahara, E Murakami, M Yamauchi, T Kawaoka, D Miki, M Tsuge, A Hiramatsu, H AbeChayama, CN Hayes, H Aikata, K Chayama	Journal of Viral Hepatitis	2020
Absence of αβ T cells accelerates disuse bone loss in male mice after spinal cord injury K Sahbani, LC Shultz, CP Cardozo, WA Bauman, HA Tawfeek	Annals of the New York Academy of Sciences	2020
Strategies to achieve immune tolerance in allogeneic solid organ transplantation S Zeng, Z Xiao, Q Wang, Y Guo, Y He, Q Zhu, Y Zou	Transplant Immunology	2019
CTLA-4 (CD152): A versatile receptor for immune-based therapy H Lingel, MC Brunner-Weinzierl	Seminars in Immunology	2019
Dendritic cells, T cells and their interaction in rheumatoid arthritis: Dendritic cells, T cells and their interaction P Wehr, H Purvis, SC Law, R Thomas	Clinical & Experimental Immunology	2019
Costimulatory blockade molecules and B-cell–mediated immune response: current knowledge and perspectives C Leibler, A Thiolat, RA Elsner, KE Karoui, C Samson, P Grimbert	Kidney International	2019
A comprehensive review on the role of co-signaling receptors and Treg homeostasis in autoimmunity and tumor immunity P Kumar, P Bhattacharya, BS Prabhakar	Journal of Autoimmunity	2018
Pain pathogenesis in rheumatoid arthritis—what have we learned from animal models?: E Krock, A Jurczak, CI Svensson	PAIN	2018
Advances in targeting co-inhibitory and co-stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy LS Kean, LA Turka, BR Blazar	Immunological Reviews	2017
Kelley and Firestein's Textbook of Rheumatology PE di Cesare, DR Haudenschild, J Samuels, SB Abramson	Kelley and Firestein's Textbook of Rheumatology	2017
Abatacept as a therapeutic option in the treatment of encapsulated peritoneal sclerosis: an experimental rat model L Bircan, S Karakose, H Unverdi, AZ Bal, S Unverdi, M Duranay	International Urology and Nephrology	2017
Interference of the T Cell and Antigen-Presenting Cell Costimulatory Pathway Using CTLA4-Ig (Abatacept) Prevents Staphylococcal Enterotoxin B Pathology SJ Whitfield, C Taylor, JE Risdall, GD Griffiths, JT Jones, ED Williamson, S Rijpkema, L Saraiva, S Vessillier, AC Green, AJ Carter	Journal of immunology (Baltimore, Md. : 1950)	2017
Co-stimulatory and Co-inhibitory Pathways in Autoimmunity Q Zhang, DA Vignali	Immunity	2016
Abatacept Inhibition of T Cell Priming in Mice by Induction of a Unique Transcriptional Profile That Reduces Their Ability to Activate Antigen-Presenting Cells: EFFECT OF ABATACEPT ON T CELLS AND APCs DURING PRIMARY IMMUNE RESPONSES A Patakas, RR Ji, W Weir, SE Connolly, RA Benson, SG Nadler, JM Brewer, IB McInnes, P Garside	Arthritis & Rheumatology	2016
Costimulation Blockade in Autoimmunity and Transplantation: The CD28 Pathway AB Adams, ML Ford, CP Larsen	Journal of immunology (Baltimore, Md. : 1950)	2016
Induction of autoimmune disease by deletion of CTLA-4 in mice in adulthood K Klocke, S Sakaguchi, R Holmdahl, K Wing	Proceedings of the National Academy of Sciences	2016
Drug Development of Therapeutic Monoclonal Antibodies DR Mould, B Meibohm	BioDrugs	2016
Analysis of Mitogen-Activated Protein Kinases in Bone and Cartilage of Patients with Rheumatoid Arthritis Treated with Abatacept K Kanbe, K Oh, J Chiba, Y Inoue, M Taguchi, A Yabuki, T Deguchi	Clinical Medicine Insights. Arthritis and Musculoskeletal Disorders	2016
Possibilities for preventive treatment in rheumatoid arthritis? Lessons from experimental animal models of arthritis: a systematic literature review and meta-analysis JS Dekkers, JW Schoones, TW Huizinga, RE Toes, AH van der Mil	Annals of the rheumatic diseases	2016
Neutrophils releasing IL-17A into NETs are essential to plasma cell differentiation in inflamed tissue dependent on IL-1R LZ Grund, I Novaski, VF Quesniaux, B Ryffel, M Lopes-Ferreira, C Lima	Autoimmunity	2016
Immunogenetics of autoimmune thyroid diseases: A comprehensive review HJ Lee, CW Li, SS Hammerstad, M Stefan, Y Tomer	Journal of Autoimmunity	2015
CD28 co-stimulation in T-cell homeostasis: a recent perspective T Hünig, N Beyersdorf, T Kerkau	ImmunoTargets and Therapy	2015
Abatacept decreases disease activity in a absence of CD4+ T cells in a collagen-induced arthritis model DT Jansen, H Bannoudi, R Arens, KL Habets, M Hameetman, TW Huizinga, JN Stoop, RE Toes	Arthritis Research & Therapy	2015
Animal models of rheumatoid arthritis: How informative are they? K McNamee, R Williams, M Seed	European Journal of Pharmacology	2015
Review: Basics of Drug Development in Rheumatology: DRUG DEVELOPMENT IN RHEUMATOLOGY P Mina-Osorio	Arthritis & Rheumatology	2015
Human Cytotoxic T Lymphocyte-Mediated Acute Liver Failure and Rescue by Immunoglobulin in Human Hepatocyte Transplant TK-NOG Mice T Uchida, N Hiraga, M Imamura, M Tsuge, H Abe, CN Hayes, H Aikata, Y Ishida, C Tateno, K Yoshizato, H Ohdan, K Murakami, K Chayama, JH Ou	Journal of virology	2015
Targeting the alternatively spliced soluble isoform of CTLA-4: prospects for immunotherapy? FJ Ward, LN Dahal, RC Khanolkar, SP Shankar, RN Barker		2014
Self in vivo production of a synthetic biological drug CTLA4Ig using a minicircle vector YA Rim, H Yi, Y Kim, N Park, H Jung, J Kim, SM Jung, SH Park, JH Ju	Scientific Reports	2014
Blockade of co-stimulation in chronic inflammatory diseases C Scheinecker	Wiener Medizinische Wochenschrift	2014
Textbook of Organ Transplantation J Stehlik, MS Kiernan, D Budge, MR Johnson	Textbook of Organ Transplantation	2014
Immune suppression in cynomolgus monkeys by XPro9523: An improved CTLA4-Ig fusion with enhanced binding to CD80, CD86 and neonatal Fc receptor FcRn MJ Bernett, SY Chu, I Leung, GL Moore, SH Lee, E Pong, H Chen, S Phung, US Muchhal, HM Horton, GA Lazar, JR Desjarlais, DE Szymkowski	mAbs	2013
Therapeutic effect of CTLA4-Ig on a murine model of primary biliary cirrhosis A Dhirapong, GX Yang, S Nadler, W Zhang, K Tsuneyama, P Leung, S Knechtle, AA Ansari, RL Coppel, FT Liu, XS He, ME Gershwin	Hepatology	2013
Targeting the B7 Family of Co-Stimulatory Molecules JR Podojil, SD Miller	BioDrugs	2013
B7 family checkpoint regulators in immune regulation and disease S Ceeraz, EC Nowak, RJ Noelle	Trends in Immunology	2013
Long Term Safety and Efficacy of Abatacept in Patients with Rheumatoid Arthritis CK Lee	Journal of Rheumatic Diseases	2013
Therapeutic Fc-Fusion Proteins A Rajpal, P Strop, YA Yeung, J Chaparro-Riggers, J Pons	Therapeutic Fc-Fusion Proteins	2013
El uso de abatacept en artritis reumatoide: revisión de la evidencia y recomendaciones EM Mola, A Balsa, VM Taboada, R Sanmartí, JL Marenco, FN Sarabia, J Gómez-Reino, JM Álvaro-Gracia, JA Ivorra, L Lojo, C Plasencia, L Carmona	Reumatología Clínica	2013
A Monovalent Anti-Human CD28 Domain Antibody Antagonist: Preclinical Efficacy and Safety SJ Suchard, PM Davis, S Kansal, DK Stetsko, R Brosius, J Tamura, L Schneeweis, J Bryson, T Salcedo, H Wang, Z Yang, CA Fleener, O Ignatovich, C Plummer, S Grant, SG Nadler	Journal of immunology (Baltimore, Md. : 1950)	2013
Immunotherapies: the blockade of inhibitory signals YL Wu, J Liang, W Zhang, Y Tanaka, H Sugiyama	International journal of biological sciences	2012
Genetic Basis of Alopecia Areata A Jabbari, L Petukhova, RM Cabral, R Clynes, AM Christiano	Dermatologic Clinics	2012
The pathogenesis of rheumatoid arthritis: new insights from old clinical data? JS Smolen, D Aletaha, K Redlich	Nature Reviews Rheumatology	2012
Abatacept Use in Rheumatoid Arthritis: Evidence Review and Recommendations EM Mola, A Balsa, VM Taboada, R Sanmartí, JL Marenco, FN Sarabia, J Gómez-Reino, JM Álvaro-Gracia, JA Ivorra, L Lojo, C Plasencia, L Carmona	Reumatología Clínica (English Edition)	2012
Abatacept: a biologic immune modulator for rheumatoid arthritis C Papagoras, AA Drosos	Expert Opinion on Biological Therapy	2011
International Review of Cell and Molecular Biology A Chavez, M Smith, D Mehta	International Review of Cell and Molecular Biology Volume 290	2011
The significance of immune-related molecule expression profiles in an animal model of Graves' disease F Ye, P Hou, X Wu, X Ma, L Gao, L Wu, L Xu, B Shi	Autoimmunity	2011
Potent Antirheumatic Activity of a New DNA Vaccine Targeted to B7-2/CD28 Costimulatory Signaling Pathway in Autoimmune Arthritis H Xue, F Liang, N Liu, X Song, F Yuan, Y Luo, X Zhao, J Long, Y Sun, Y Xi	Human Gene Therapy	2010
Abatacept limits breach of self-tolerance in a murine model of arthritis via effects on the generation of T follicular helper cells AM Platt, VB Gibson, A Patakas, RA Benson, SG Nadler, JM Brewer, IB McInnes, P Garside	Journal of immunology (Baltimore, Md. : 1950)	2010
Targeting lymphocyte co-stimulation: From bench to bedside NJ Felix, A Suri, L Salter-Cid, SG Nadler, S Gujrathi, M Corbo, R Aranda	Autoimmunity	2010
CTLA-4Ig blocks the development and progression of citrullinated fibrinogen-induced arthritis in DR4-transgenic mice D Yue, W Brintnell, LA Mannik, DA Christie, SM Haeryfar, J Madrenas, S Chakrabarti, DA Bell, E Cairns	Arthritis & Rheumatism	2010
Introduction of a Biologic Agent into the Clinic V Strand, J Smith	Targeted Treatment of the Rheumatic Diseases	2010
Immunoendocrinology: Scientific and Clinical Aspects GS Eisenbarth		2010
Specific Btk inhibition suppresses B cell– and myeloid cell–mediated arthritis JA Paolo, T Huang, M Balazs, J Barbosa, KH Barck, BJ Bravo, RA Carano, J Darrow, DR Davies, LE DeForge, L Diehl, R Ferrando, SL Gallion, AM Giannetti, P Gribling, V Hurez, SG Hymowitz, R Jones, JE Kropf, WP Lee, PM Maciejewski, SA Mitchell, H Rong, BL Staker, JA Whitney, S Yeh, WB Young, C Yu, J Zhang, K Reif, KS Currie	Nature Chemical Biology	2010
Abatacept Does Not Induce Direct Gene Expression Changes in Antigen-Presenting Cells JA Carman, PM Davis, WP Yang, J Zhu, H Chang, A He, A Truong, SJ Suchard, SG Nadler	Journal of Clinical Immunology	2009
The clinical utility of inhibiting CD28-mediated costimulation PS Linsley, SG Nadler	Immunological Reviews	2009
Anti-CD20 Antibody Rituximab in the Treatment of Rheumatoid Arthritis R Korhonen, E Moilanen	Basic & Clinical Pharmacology & Toxicology	2009
Abatacept, a Novel CD80/86-CD28 T Cell Co-stimulation Modulator, in the Treatment of Rheumatoid Arthritis R Korhonen, E Moilanen	Basic & Clinical Pharmacology & Toxicology	2009
Pharmacokinetics of CTLA4Ig fusion protein in healthy volunteers and patients with rheumatoid arthritis Y Ma, B Lin, B Lin, S Hou, W Qian, J Li, M Tan, J Ma, B Li, H Wang, A Wen, Y Guo	Acta Pharmacologica Sinica	2009
Kelley's Textbook of Rheumatology J Degroot, AM Zuurmond, PP Tak	Kelley's Textbook of Rheumatology	2009
The etiology of autoimmune thyroid disease: a story of genes and environment Y Tomer, A Huber	Journal of Autoimmunity	2009
New Therapeutic Targets in Rheumatoid Arthritis PP Tak		2009
Spontaneous colitis occurrence in transgenic mice with altered B7-mediated costimulation G Kim, O Turovskaya, M Levin, FR Byrne, JS Whoriskey, JG McCabe, M Kronenberg	Journal of immunology (Baltimore, Md. : 1950)	2008
Distinct in vivo roles of CD80 and CD86 in the effector T-cell responses inducing antigen-induced arthritis D Odobasic, MT Leech, JR Xue, SR Holdsworth	Immunology	2008
Abatacept: the evidence for its place in the treatment of rheumatoid arthritis MD Köller	Core evidence	2008
Abatacept modulates human dendritic cell-stimulated T-cell proliferation and effector function independent of IDO induction PM Davis, SG Nadler, DK Stetsko, SJ Suchard	Clinical Immunology	2008
Modelos animales en la artritis reumatoide MG Uriel	Reumatología Clínica	2008
Genetic regulation of T regulatory, CD4, and CD8 cell numbers by the arthritis severity loci Cia5a, Cia5d, and the MHC/Cia1 in the rat M Brenner, T Laragione, NC Yarlett, PS Gulko	Molecular Medicine	2007
The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: Back to the future EM Jacobson, Y Tomer	Journal of Autoimmunity	2007
The Genetic Basis of Thyroid Autoimmunity EM Jacobson, Y Tomer	Thyroid	2007
Paradoxical Effect of Reduced Costimulation in T Cell-Mediated Colitis G Kim, M Levin, SP Schoenberger, A Sharpe, M Kronenberg	Journal of immunology (Baltimore, Md. : 1950)	2007
Genetic regulation of T regulatory, CD4, and CD8 cell numbers by the arthritis severity loci Cia5a, Cia5d, and the MHC/Cia1 in the rat. Brenner M, Laragione T, Yarlett NC, Gulko PS	Molecular Medicine	2007
Modification of accessory molecule signaling MK Crow	Springer Seminars in Immunopathology	2006
CTLA-4IG suppresses reactive oxygen species by preventing synovial adherent cell-induced inactivation of rap1, a ras family GTPASE mediator of oxidative stress in rheumatoid arthritis T cells PH Remans, CA Wijbrandts, ME Sanders, RE Toes, FC Breedveld, PP Tak, JM van Laar, KA Reedquist	Arthritis & Rheumatism	2006
Co-stimulatory Blockade-A Pathway to Tolerance? EM Bolton, JA Bradley	American Journal of Transplantation	2006
Control of Memory CD4 T Cell Recall by the CD28/B7 Costimulatory Pathway MP Ndejembi, JR Teijaro, DS Patke, AW Bingaman, MR Chandok, A Azimzadeh, SG Nadler, DL Farber	Journal of immunology (Baltimore, Md. : 1950)	2006
The evolving clinical profile of abatacept (CTLA4-Ig): a novel co-stimulatory modulator for the treatment of rheumatoid arthritis EM Ruderman, RM Pope	Arthritis Research & Therapy	2005
Co-stimulatory blockade as therapy for rheumatoid arthritis SL Mackie, EM Vital, F Ponchel, P Emery	Current Rheumatology Reports	2005
Prophylactic administration of abatacept prevents disease and bone destruction in a rat model of collagen-induced arthritis C Kliwinski, D Kukral, J Postelnek, B Krishnan, L Killar, A Lewin, S Nadler, R Townsend	Journal of Autoimmunity	2005
Cloning, Structural Organization and Chromosomal Mapping of Rat Costimulatory Molecule 4-1BBL QM DONG, LJ MA, GB ZHANG, YF WU, JY SHEN, Y CHEN, YJ CHEN, XK PU, SY HANG, XG ZHANG	Acta Biochimica et Biophysica Sinica	2005
Therapeutic peptidomimetic strategies for autoimmune diseases: costimulation blockade* SD Allen, SV Rawale, CC Whitacre, PT Kaumaya	Journal of Peptide Research	2005
CTLA-4 expression in T cells of patients with atopic dermatitis SY Choi, MH Sohn, BC Kwon, KE Kim	Pediatric Allergy and Immunology	2005
LEW.1WR1 Rats Develop Autoimmune Diabetes Spontaneously and in Response to Environmental Perturbation JP Mordes, DL Guberski, JH Leif, BA Woda, JF Flanagan, DL Greiner, EH Kislauskis, RS Tirabassi	Diabetes	2005
CTLA-4 (CD152) and its involvement in autoimmune disease D Holmberg, CM Cilio, M Lundholm, V Motta	Autoimmunity	2005
Type I collagen is the autoantigen in experimental autoimmune anterior uveitis NS Bora, JH Sohn, SG Kang, JM Cruz, H Nishihori, HJ Suk, Y Wang, HJ Kaplan, PS Bora	Journal of immunology (Baltimore, Md. : 1950)	2004
Detection of circulating soluble CD28 in patients with systemic lupus erythematosus, primary Sjogren's syndrome and systemic sclerosis M Hebbar, P Jeannin, G Magistrelli, PY Hatron, E Hachulla, B Devulder, JY Bonnefoy, Y Delneste	Clinical & Experimental Immunology	2004
CTLA4-Ig fusion proteins: promise for improved therapy of transplant rejection and autoimmune diseases FJ Dumont	Therapy	2004
CTLA4–Ig fusion proteins: promise for improved therapy of transplant rejection and autoimmune diseases FJ Dumont	Therapy	2004
B-cell biology E Weinstein, E Peeva, C Putterman, B Diamond	Rheumatic Disease Clinics of North America	2004
Costimulatory molecules and T-cell–B-cell interactions MK Crow	Rheumatic Disease Clinics of North America	2004
Costimulation Blockade in the Treatment of Rheumatic Diseases: SN Liossis, PP Sfikakis	BioDrugs	2004
Intracellular Signaling and Cytokine Induction upon Interactions of Porphyromonas gingivalis Fimbriae with Pattern‐Recognition Receptors G Hajishengallis, H Sojar, RJ Genco, E DeNardin	Immunological Investigations	2004
Antigen-Specific T-Cell Downregulation by Human Dendritic Cells Following Blockade of NF-kappaB VL Calder, J Bondeson, FM Brennan, BM Foxwell, M Feldmann	Scandinavian Journal of Immunology	2003
T-Cell-Activation Inhibitors in Rheumatoid Arthritis: HM Lorenz	BioDrugs	2003
Molekularmedizinische Grundlagen von rheumatischen Erkrankungen D Ganten, K Ruckpaul, S Gay, JR Kalden		2003
Role of Hypolipidemic Drug Clofibrate in Altering Iron Regulatory Proteins IRP1 and IRP2 Activities and Hepatic Iron Metabolism in Rats Fed a Low-Iron Diet HL Huang, NS Shaw	Toxicology and Applied Pharmacology	2002
Gene therapy for rheumatoid arthritis N Bessis, C Doucet, V Cottard, AM Douar, H Firat, C Jorgensen, M Mezzina, MC Boissier	The Journal of Gene Medicine	2002
Targeting T cell costimulation in autoimmune disease MK Racke, RW Stuart	Expert Opinion on Therapeutic Targets	2002
CD40/CD40L Interaction is Essential for the Induction of EAE in the Absence of CD28-Mediated Co-stimulation AM Girvin, MC Canto, SD Miller	Journal of Autoimmunity	2002
Interactions of Oral Pathogens With Toll-Like Receptors: Possible Role in Atherosclerosis G Hajishengallis, A Sharma, MW Russell, RJ Genco	Annals of Periodontology	2002
Involvement of receptor activator of NFκB ligand and tumor necrosis factor-α in bone destruction in rheumatoid arthritis E Romas, MT Gillespie, TJ Martin	Bone	2002
Amelioration of collagen-induced arthritis by blockade of inducible costimulator-B7 homologous protein costimulation H Iwai, Y Kozono, S Hirose, H Akiba, H Yagita, K Okumura, H Kohsaka, N Miyasaka, M Azuma	Journal of immunology (Baltimore, Md. : 1950)	2002
POTENTIAL BIOLOGIC AGENTS FOR TREATING RHEUMATOID ARTHRITIS LW Moreland	Rheumatic Disease Clinics of North America	2001
IFN-β1a Modulates the Expression of CTLA-4 and CD28 Splice Variants in Human Mononuclear Cells: Induction of Soluble Isoforms M Giorelli, P Livrea, G Defazio, F Ricchiuti, E Pagano, M Trojano	Journal of Interferon & Cytokine Research	2001
The immune tolerance network and rheumatic disease: Immune tolerance comes to the clinic B Diamond, J Bluestone, D Wofsy	Arthritis & Rheumatism	2001
Interference with CD28, CD80, CD86 or CD152 in Collagen-induced Arthritis. Limited Role of IFN-γ in Anti-B7-mediated Suppression of Disease AC Tellander, U Pettersson, A Runström, M Andersson, E Michaëlsson	Journal of Autoimmunity	2001
Gene therapy in rheumatic diseases MJ Vervoordeldonk, PP Tak	Best Practice & Research Clinical Rheumatology	2001
Manipulation of costimulatory pathways in autoimmune diseases A Nakajima	Modern Rheumatology	2001
Involvement of T-Lymphocytes in Periodontal Disease and in Direct and Indirect Induction of Bone Resorption MA Taubman, T Kawai	Critical Reviews in Oral Biology & Medicine	2001
B7 Interactions with CD28 and CTLA-4 Control Tolerance or Induction of Mucosal Inflammation in Chronic Experimental Colitis Z Liu, K Geboes, P Hellings, P Maerten, H Heremans, P Vandenberghe, L Boon, P van Kooten, P Rutgeerts, JL Ceuppens	Journal of immunology (Baltimore, Md. : 1950)	2001
Advances in the therapy of rheumatoid arthritis with biological agents IC Chikanza, LI Sakkas	Expert Opinion on Emerging Drugs	2000
Adenovirus-mediated gene transfer of CTLA-4Ig fusion protein in the suppression of experimental autoimmune arthritis E Quattrocchi, MJ Dallman, M Feldmann	Arthritis & Rheumatism	2000
Characterization of Rat OX40 Ligand by Monoclonal Antibody Y Satake, H Akiba, K Takeda, M Atsuta, H Yagita, K Okumura	Biochemical and Biophysical Research Communications	2000
Requirement of B7 Costimulation for Th1-Mediated Inflammatory Bone Resorption in Experimental Periodontal Disease T Kawai, R Eisen-Lev, M Seki, JW Eastcott, ME Wilson, MA Taubman	Journal of immunology (Baltimore, Md. : 1950)	2000
Gene therapy for autoimmune disorders C H Evans, S C Ghivizzani, T J Oligino, P D Robbins	Journal of Clinical Immunology	2000
Dendritic cells: The driving force behind autoimmunity in rheumatoid arthritis? AL Pettit, RA Thomas	Immunology and Cell Biology	1999
Antigen-presenting cells in rheumatoid arthritis R Thomas	Springer Seminars in Immunopathology	1998
Why Do We Need New Treatments for Rheumatoid Arthritis?* IC Chikanza, S Jawed, D Naughton, DR Blake	Journal of Pharmacy and Pharmacology	1998
An appraisal of T cell subsets and the potential for autoimmune injury CJ Kelly, Y Frishberg, DP Gold	Kidney International	1998
Tolerogenic activity of polyethylene glycol-conjugated lysozyme distinct from that of the native counterpart HO Ito, T So, M Hirata, T Koga, T Ueda, T Imoto	Immunology	1998
CTLA4 codon 17 dimorphism in patients with rheumatoid arthritis C Seidl, H Donner, B Fischer, KH Usadel, E Seifried, JP Kaltwasser, K Badenhoop	Tissue Antigens	1998
Identification of Rat OX40 Ligand by Molecular Cloning H Akiba, M Atsuta, H Yagita, K Okumura	Biochemical and Biophysical Research Communications	1998
Control of Herpetic Stromal Keratitis Using CTLA4Ig Fusion Protein S Gangappa, E Manickan, BT Rouse	Clinical Immunology and Immunopathology	1998
Biologic agents for treating rheumatoid arthritis. Concepts and progress LW Moreland, LW Heck, WJ Koopman	Arthritis & Rheumatism	1997
Clinical and Histological Assessment of Collagen-Induced Arthritis Progression in the Diabetes-Resistant BB/Wor Rat DB Knoerzer, MG Donovan, BD Schwartz, LJ Mengle-Gaw	Toxicologic pathology	1997
Prevention and amelioration of collagen-induced arthritis by blockade of the CD28 co-stimulatory pathway: requirement for both B7-1 and B7-2 LM Webb, MJ Walmsley, M Feldmann	European Journal of Immunology	1996
Costimulatory B7 Molecules in the Pathogenesis of Infectious and Autoimmune Diseases FH Epstein, H Reiser, MJ Stadecker	New England Journal of Medicine	1996
Section Review Pulmonary-Allergy, Dermatological, Gastrointestinal & Arthritis: The current status and future prospects for biological targeted therapies for rheumatoid arthritis IC Chikanza, L Fernandes	Expert Opinion on Investigational Drugs	1996

Advertisement